H
HilleVax D
D
HLVX
1.85300
USD
-0.02
(-1.17%)
مغلق
حجم التداول
1,948
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
92,836,551
العنوان: HilleVax
القطاع: Healthcare
الصناعة: Biotechnology
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.